期刊文献+

50例大肠癌组织中Survivin及其剪接变异体表达的实验研究

EXPRESSION OF SURVIVIN AND ITS SPLICE VARIANTS IN 50 CASES OF COLORECTAL CANCER TISSUES
下载PDF
导出
摘要 目的:探讨大肠癌组织中Survivin及其剪接变异体Survivin-ΔEx3、Survi-vin-2B mRNA在大肠癌组织的表达规律。方法:采用逆转录-聚合酶链反应(RT-PCR)检测50例(高分化20例,中低分化30例)大肠癌组织标本中Survivin及其剪接变异体Survivin-ΔEx3、Survivin-2B mRNA表达。结果:Survivin、Survivin-ΔEx3及Survivin-2B mRNA在大肠癌中表达阳性率分别为70.0%、34.0%、26.0%,大肠癌高分化组和中低分化组Survivin mRNA阳性表达率有显著差异;Survivin-ΔEx3mRNA阳性表达率有上升趋势,Survivin-2B mRNA阳性表达率有下降趋势。50例大肠癌组织中表达Survivin-△Ex3和(或)Survivin-2B者均有Survivin表达。结论:提示Survivin在大肠癌的发展过程中具有重要作用;Survivin及其剪接变异体Survivin-ΔEx3具有抗凋亡作用;Survivin-2B促凋亡,具有保护作用;Survivin基因有望作为大肠癌生物治疗的一个良好分子靶点。 Objective:To investigate the expression of Survivin and its splice variants Survivin-△Ex3,Survivin-2B mRNA in colorectal cancer. Methods:The expression levels of mRNA of Survivin and its splice variants Survivin-△Ex3 and Survivin-2B were in vestigated by reverse transcription polymerase chain reaction (RT-PCR) in 50 cases of colorectal cancer tissues (20 cases of high differentiation & 30 cases of moderate/poor differentiation).Results:The positive expression rate of mRNA of Survivin,Survivin-△Ex3 and Survivin-2B in colorectal cancer were 70.0%, 34.0% and 26.0% respectively. There were significant differences between the positive expression rates of mRNA of Survivin in high differentiation and moderation/poor differentiation colorectal cancer. The positive expression rates of mRNA of Survivin-△Ex3 had escalating trend.the positive expression rates of mRNA of Survivin-2B had moderating trend.The expression of Survivin have been found in any tissue where survinvin-△Ex3 and (or) Survivin-2B express.Conclusion:Survivin plays an important role in colorectal cancer. Together with its splice variants Survivin-△Ex3, Survivin is an inhibitor of apoptosis protein. Meanwhile, Survivin-2B is a promoting apoptosis factor. Survivin is an ideal molecular target for biotherapy of colorectal cancer.
出处 《泸州医学院学报》 2009年第5期469-472,共4页 Journal of Luzhou Medical College
关键词 SURVIVIN 变异体 大肠癌 Survivin Variants Colorectal cancer
  • 相关文献

参考文献8

  • 1Badran A, Yoshida A, Ishikawa K, et al. Identification of a Novel Splice Variant of the Human Anti Apoptopsis Gene Survivin[J] Biochem Biophys Res Commun, 2004; 314(3): 902.
  • 2Caldas H, Honsey LE, Altura RA. Survivin 2alpha: A Novel Survivin Splice Variant Expressed in Human Malignancies [J ]. Mol Cancer, 2005 ; 4(1): 11.
  • 3Ryan B, O Donovan N, Browne B, et al. Expression of survivin and its sphce variants surviving-2B and survivindeltaEx3 in breast cancer[J]. BrJ Cancer, 2005 ;92(1): 120.
  • 4Mahotka C, Krieg T, Krieg A, et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas[J]. IntJ cancer, 2002; 100(1): 30.
  • 5Takashima H, Nakajima T, Moriguchi M, et al. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma [J]. laverlnt. 2005 ; 25(1): 77.
  • 6Meng H, Lu C, Mabuchi H, et al. Prognostic significance and different properties of survivin splicing variants in gastric cancer[J]. Cancer Lett, 2004;216(2):147.
  • 7Nakagawa Y, Yamaguchi S, Hasegawa M, et al. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia[J].Leuk Res, 2004 ;28(5) :487.
  • 8Taubert H, Kappler M, Bache M, et al. Elevated Expression of Surviving Splice Variants Predicts a Poor Outcome for Soft Tissue Sarcomas Patients [J]. Oncogene, 2005 ;24 (33): 5258.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部